Boston Tech
Arbor Biotechnologies Advances Three ALS Candidates, With Molecular Carry-On Luggage
Cambridge’s Arbor Biotechnologies advances three ALS gene-editing candidates, targeting brain delivery and 2027 filings. A serious bet, still preclinical.